Showing results (411-420 of 504) with videos related to

Sort By:
Pageof 51
European Respiratory Review : an Official Journal of the European Respiratory Society|February 10, 2022
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertensionLaurent Savale, Marloes Huitema, Oksana Shlobin, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanismsSouheil El-Chemaly, Daniela Malide, Enrique Zudaire, et al.
The European Respiratory Journal|August 8, 2015
Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restrictionGanesh Raghu, Steven D Nathan, Juergen Behr, et al.
Hepatology Communications|September 14, 2020
Natural Course of Pediatric Portal HypertensionAl-Faraaz Kassam, Gillian R Goddard, Michael E Johnston, et al.
Critical Care Explorations|April 23, 2025
Surfactant Protein D and Club Cell Secretory Protein as Biomarkers of Disease Severity and Fostamatinib Efficacy in Severe COVID-19Marcos J Ramos-Benitez, Rui Miao, Andrea P Rivera-Torres, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 22, 2025
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failureMichael B Keller, David Newman, Muhtadi Alnababteh, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 20, 2019
Updates in Pediatric Pancreatology: Proceedings of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Frontiers in Pediatric Pancreatology SymposiumAmit S Grover, Alvin J Freeman, Maisam Abu-El-Haija, et al.
BMC Cancer|November 16, 2019
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinomaHannah L Buckley, Fiona J Collinson, Gemma Ainsworth, et al.
The Lancet. Oncology|February 15, 2021
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation studyMahrukh M Syeda, Jennifer M Wiggins, Broderick C Corless, et al.
Pageof 51